Advertisement

Applied Microbiology and Biotechnology

, Volume 104, Issue 3, pp 981–987 | Cite as

Modulation effect of tea consumption on gut microbiota

  • Yu-Chuan Liu
  • Xin-Yu Li
  • Liang ShenEmail author
Mini-Review
  • 173 Downloads

Abstract

Tea is one of the most popular beverages in the world and possesses a wide range of beneficial effects for human health. The modulation of tea on gut microbiota has gained much interest in recent years. The present study discussed the modulation effect of various types of tea on gut microbiota, which plays crucial roles in human health, as investigated by in vitro animal and human studies. The currently available findings from a total of 23 studies support the modulation effects of tea liquid, tea extract, and its major active components, including polyphenols, polysaccharides, and teasaponin, on gut microbiota. Overall, tea possesses prebiotic-like effect and can alleviate the gut microbiota dysbiosis induced by high-fat diet in gut microbiota, despite the detailed bacterial taxa may alter depending on the types of tea supplemented. Current evidence implies that the modulation effect on gut microbiota may be an important action mechanism underlying the beneficial effect of tea consumption in daily life and also the great potential of strategically chosen tea extract to develop functional foods.

Keywords

Tea Gut microbiota Modulation Polyphenols 

Notes

Author contributions

LS conceived and directed the study and revised the manuscript. YCL and XYL collected and analyzed the data, and drafted the manuscript.

Funding information

This work was supported by the Shandong Provincial Natural Science Foundation (Grant No. ZR2018MH010) and University Youth Innovation Team of Shandong Province (Grant No. 2019KJK017).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

Not needed.

References

  1. Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF (2009) Parkinson’s disease and tea: a quantitative review. J Am Coll Nutr 28:1–6PubMedGoogle Scholar
  2. Cabrera C, Artacho R, Gimenez R (2006) Beneficial effects of green tea--a review. J Am Coll Nutr 25:79–99PubMedGoogle Scholar
  3. Chen G, Xie M, Dai Z, Wan P, Ye H, Zeng X, Sun Y (2018a) Kudingcha and Fuzhuan brick tea prevent obesity and modulate gut microbiota in high-fat diet fed mice. Mol Nutr Food Res 62:e1700485PubMedGoogle Scholar
  4. Chen G, Xie M, Wan P, Chen D, Dai Z, Ye H, Hu B, Zeng X, Liu Z (2018b) Fuzhuan brick tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota. J Agric Food Chem 66:2783–2795PubMedGoogle Scholar
  5. Chen G, Xie M, Wan P, Chen D, Ye H, Chen L, Zeng X, Liu Z (2018c) Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro by human intestinal microbiota of polysaccharides from Fuzhuan brick tea. Food Chem 244:331–339PubMedGoogle Scholar
  6. Chen Y, Zhang X, Cheng L, Zheng X, Zhang Z (2018d) The evaluation of the quality of Feng Huang oolong teas and their modulatory effect on intestinal microbiota of high-fat diet-induced obesity mice model. Int J Food Sci Nutr 69:842–856PubMedGoogle Scholar
  7. Cheng M, Zhang X, Miao Y, Cao J, Wu Z, Weng P (2017) The modulatory effect of (–)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3 Me) on intestinal microbiota of high fat diet-induced obesity mice model. Food Res Int 92:9–16PubMedGoogle Scholar
  8. Cheng M, Zhang X, Zhu J, Cheng L, Cao J, Wu Z, Weng P, Zheng X (2018) A metagenomics approach to the intestinal microbiome structure and function in high fat diet-induced obesity mice fed with oolong tea polyphenols. Food Funct 9:1079–1087PubMedGoogle Scholar
  9. Cooper R, Morre DJ, Morre DM (2005) Medicinal benefits of green tea: part I. Review of noncancer health benefits. J Altern Complement Med 11:521–528PubMedGoogle Scholar
  10. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Costea PI, Kultima JR, Li J, Jorgensen T, Levenez F, Dore J, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266PubMedPubMedCentralGoogle Scholar
  11. Gao X, Xie Q, Kong P, Liu L, Sun S, Xiong B, Huang B, Yan L, Sheng J, Xiang H (2018) Polyphenol- and caffeine-rich postfermented Pu-erh tea improves diet-induced metabolic syndrome by remodeling intestinal homeostasis in mice. Infect Immun 86:e00601–e00617PubMedGoogle Scholar
  12. Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, Zhang Y, Lei S, Wang S, Kuang J, Han X, Wei M, You Y, Li M, Li Y, Liang D, Liu J, Chen T, Yan C, Wei R, Rajani C, Shen C, Xie G, Bian Z, Li H, Zhao A, Jia W (2019) Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun 10:4971PubMedPubMedCentralGoogle Scholar
  13. Henning SM, Yang J, Hsu M, Lee RP, Grojean EM, Ly A, Tseng CH, Heber D, Li Z (2018) Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice. Eur J Nutr 57:2759–2769PubMedGoogle Scholar
  14. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P (2011) Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 16:157–163PubMedGoogle Scholar
  15. Ikarashi N, Ogawa S, Hirobe R, Kon R, Kusunoki Y, Yamashita M, Mizukami N, Kaneko M, Wakui N, Machida Y, Sugiyama K (2017) Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. Eur J Pharm Sci 100:211–218PubMedGoogle Scholar
  16. Jacob SA, Khan TM, Lee LH (2017) The effect of green tea consumption on prostate cancer risk and progression: a systematic review. Nutr Cancer 69:353–364PubMedGoogle Scholar
  17. Janssens PL, Penders J, Hursel R, Budding AE, Savelkoul PH, Westerterp-Plantenga MS (2016) Long-term green tea supplementation does not change the human gut microbiota. PLoS One 11:e0153134PubMedPubMedCentralGoogle Scholar
  18. Jin JS, Touyama M, Hisada T, Benno Y (2012) Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol Immunol 56:729–739PubMedGoogle Scholar
  19. Khan N, Mukhtar H (2018) Tea polyphenols in promotion of human health. Nutrients E39PubMedCentralGoogle Scholar
  20. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296:1255–1265PubMedGoogle Scholar
  21. Liao ZL, Zeng BH, Wang W, Li GH, Wu F, Wang L, Zhong QP, Wei H, Fang X (2016) Impact of the consumption of tea polyphenols on early atherosclerotic lesion formation and intestinal Bifidobacteria in high-fat-fed ApoE−/− mice. Front Nutr 3:42PubMedPubMedCentralGoogle Scholar
  22. Liu Z, Chen Z, Guo H, He D, Zhao H, Wang Z, Zhang W, Liao L, Zhang C, Ni L (2016) The modulatory effect of infusions of green tea, oolong tea, and black tea on gut microbiota in high-fat-induced obese mice. Food Funct 7:4869–4879PubMedGoogle Scholar
  23. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727–747PubMedGoogle Scholar
  24. Marques FZ, Mackay CR, Kaye DM (2018) Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol 15:20–32PubMedGoogle Scholar
  25. McKay DL, Blumberg JB (2002) The role of tea in human health: an update. J Am Coll Nutr 21:1–13PubMedGoogle Scholar
  26. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP (2013) Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58:120–127PubMedGoogle Scholar
  27. Nakagawa K, Miyazawa T (1997) Absorption and distribution of tea catechin, (−)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo) 43:679–684Google Scholar
  28. Ning JM, Li DX, Luo XJL, Ding D, Song YS, Zhang ZZ, Wan XC (2016) Stepwise identification of six tea (Camellia sinensis (L.)) categories based on catechins, caffeine, and theanine contents combined with fisher discriminant analysis. Food Anal Methods 9:3242–3250Google Scholar
  29. O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7:688–693PubMedPubMedCentralGoogle Scholar
  30. Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, Seripa D, Sabba C, Pilotto A, Logroscino G (2015) Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging 19:313–328PubMedGoogle Scholar
  31. Roh E, Kim JE, Kwon JY, Park JS, Bode AM, Dong Z, Lee KW (2017) Molecular mechanisms of green tea polyphenols with protective effects against skin photoaging. Crit Rev Food Sci Nutr 57(8):1631–1637PubMedGoogle Scholar
  32. Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13:800–812PubMedPubMedCentralGoogle Scholar
  33. Seo DB, Jeong HW, Cho D, Lee BJ, Lee JH, Choi JY, Bae IH, Lee SJ (2015) Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice. J Med Food 18:549–556PubMedGoogle Scholar
  34. Seo DB, Jeong HW, Kim YJ, Kim S, Kim J, Lee JH, Joo K, Choi JK, Shin SS, Lee SJ (2017) Fermented green tea extract exhibits hypolipidaemic effects through the inhibition of pancreatic lipase and promotion of energy expenditure. Br J Nutr 117:177–186PubMedGoogle Scholar
  35. Shahi SK, Freedman SN, Mangalam AK (2017) Gut microbiome in multiple sclerosis: the players involved and the roles they play. Gut Microbes 8:607–615PubMedPubMedCentralGoogle Scholar
  36. Shen L, Ji HF (2016) Intestinal microbiota and metabolic diseases: pharmacological implications. Trends Pharmacol Sci 37:169–171PubMedGoogle Scholar
  37. Shen L, Ji HF (2019) Bidirectional interactions between dietary curcumin and gut microbiota. Crit Rev Food Sci Nutr 59:2896–2902PubMedGoogle Scholar
  38. Shen L, Liu L, Ji HF (2017) Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state. J Alzheimers Dis 56:385–390PubMedGoogle Scholar
  39. Shen L, Liu L, Li XY, Ji HF (2019) Regulation of gut microbiota in Alzheimer’s disease mice by silibinin and silymarin and their pharmacological implications. Appl Microbiol Biotechnol 103:7141–7149PubMedGoogle Scholar
  40. Singh DP, Singh J, Boparai RK, Zhu J, Mantri S, Khare P, Khardori R, Kondepudi KK, Chopra K, Bishnoi M (2017) Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice. Pharmacol Res 123:103–113PubMedGoogle Scholar
  41. Sun H, Chen Y, Cheng M, Zhang X, Zheng X, Zhang Z (2018) The modulatory effect of polyphenols from green tea, oolong tea and black tea on human intestinal microbiota in vitro. J Food Sci Technol 55:399–407PubMedGoogle Scholar
  42. Wang L, Zeng B, Liu Z, Liao Z, Zhong Q, Gu L, Wei H, Fang X (2018) Green tea polyphenols modulate colonic microbiota diversity and lipid metabolism in high-fat diet treated HFA mice. J Food Sci Technol 83:864–873Google Scholar
  43. Wang S, Huang XF, Zhang P, Newell KA, Wang H, Zheng K, Yu Y (2017) Dietary teasaponin ameliorates alteration of gut microbiota and cognitive decline in diet-induced obese mice. Sci Rep 7:12203PubMedPubMedCentralGoogle Scholar
  44. Wang YF, Shao SH, Xu P, Chen H, Lin-Shiau SY, Deng YT, Lin JK (2012) Fermentation process enhanced production and bioactivities of oolong tea polysaccharides. Food Res Int 46:158–166Google Scholar
  45. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109–1113PubMedPubMedCentralGoogle Scholar
  46. Wu CD, Wei GX (2002) Tea as a functional food for oral health. Nutrition 18:443–444PubMedGoogle Scholar
  47. Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manneras-Holm L, Stahlman M, Olsson LM, Serino M, Planas-Felix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernandez-Real JM, Backhed F (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858PubMedGoogle Scholar
  48. Yuan X, Long Y, Ji Z, Gao J, Fu T, Yan M, Zhang L, Su H, Zhang W, Wen X, Pu Z, Chen H, Wang Y, Gu X, Yan B, Kaliannan K, Shao Z (2018) Green tea liquid consumption alters the human intestinal and oral microbiome. Mol Nutr Food Res 62:e1800178PubMedGoogle Scholar
  49. Zhang X, Chen Y, Zhu J, Zhang M, Ho CT, Huang Q, Cao J (2018) Metagenomics analysis of gut microbiota in a high fat diet-induced obesity mouse model fed with (−)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3 Me). Mol Nutr Food Res 62:e1800274PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Biomedical ResearchShandong University of TechnologyZiboPeople’s Republic of China
  2. 2.Zibo Key Laboratory for Neurodegenerative Diseases Drug development, Shandong Provincial Research Center for Bioinformatic Engineering and Technique, School of Life SciencesShandong University of TechnologyZiboPeople’s Republic of China

Personalised recommendations